Entity Details

Primary name FHL1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ13642
EntryNameFHL1_HUMAN
FullNameFour and a half LIM domains protein 1
TaxID9606
Evidenceevidence at protein level
Length323
SequenceStatuscomplete
DateCreated1997-11-01
DateModified2021-06-02

Ontological Relatives

GenesFHL1

GO terms

Show/Hide Table
GOName
GO:0003254 regulation of membrane depolarization
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005925 focal adhesion
GO:0007517 muscle organ development
GO:0009887 animal organ morphogenesis
GO:0010972 negative regulation of G2/M transition of mitotic cell cycle
GO:0030154 cell differentiation
GO:0030308 negative regulation of cell growth
GO:0043268 positive regulation of potassium ion transport
GO:0044325 transmembrane transporter binding
GO:0046872 metal ion binding
GO:1901016 regulation of potassium ion transmembrane transporter activity
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR001781 Zinc finger, LIM-typeDomainDomain
IPR042997 Four and a half LIM domains protein 1FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
300717 OMIMReducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset (RBMX1A)A rare myopathy clinically characterized by rapidly progressive muscular weakness, and pathologically by the presence of intracytoplasmic inclusion bodies strongly stained by menadione-linked alpha-glycerophosphate dehydrogenase in the absence of substrate, alpha-glycerophosphate. The term 'reducing body' refers to the reducing activity of the inclusions to nitroblue tetrazolium in the absence of substrate. This condition is also commonly associated with rimmed vacuoles and cytoplasmic bodies. Death in childhood is frequent in the severe form of the disease, due to respiratory failure. The disease is caused by variants affecting the gene represented in this entry.
300718 OMIMReducing body myopathy, X-linked 1B, with late childhood or adult onset (RBMX1B)A rare myopathy clinically characterized by rapidly progressive muscular weakness, and pathologically by the presence of intracytoplasmic inclusion bodies strongly stained by menadione-linked alpha-glycerophosphate dehydrogenase in the absence of substrate, alpha-glycerophosphate. The term 'reducing body' refers to the reducing activity of the inclusions to nitroblue tetrazolium in the absence of substrate. This condition is also commonly associated with rimmed vacuoles and cytoplasmic bodies. The disease is caused by variants affecting the gene represented in this entry.
300280 OMIMUruguay faciocardiomusculoskeletal syndrome (FCMSU)An X-linked recessive syndrome characterized by brachyturricephaly, pugilistic coarse facies, a muffled voice, cardiomyopathy, muscular hypertrophy, broad hands, wide feet with progressive pes cavus deformities, dislocation of toes, variable congenital hip dislocation, and scoliosis. The disease is caused by variants affecting the gene represented in this entry.
300695 OMIMScapuloperoneal myopathy, X-linked dominant (SPM)A disease characterized by progressive muscle weakness and wasting, upper and lower limbs weakness, foot drop, scapular winging, and myopathic changes on muscle biopsy. Most affected individuals become wheelchair-bound. The disease is caused by variants affecting the gene represented in this entry.
300696 OMIMEmery-Dreifuss muscular dystrophy 6, X-linked (EDMD6)A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry.
300696 OMIMEmery-Dreifuss muscular dystrophy 6, X-linked (EDMD6)A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. The disease is caused by variants affecting the gene represented in this entry.

Interactions

61 interactions

InteractorPartnerSourcesPublicationsLink
FHL1_HUMANNRIP1_HUMANBioGRID, IntAct19401155 details
FHL1_HUMANPRIO_HUMANBioGRID, IntAct, UniProt18482256 28671123 details
FHL1_HUMANPP2AB_HUMANMINT20969868 details
FHL1_HUMANAKA12_HUMANBioGRID, IntAct, MINT21900206 23414517 details
FHL1_HUMANDREB_HUMANBioGRID, MINT21900206 details
FHL1_HUMANDEAF1_HUMANBioGRID, MINT21900206 details
FHL1_HUMANEED_HUMANBioGRID, MINT21900206 details
FHL1_HUMANHES1_HUMANBioGRID, MINT21900206 details
FHL1_HUMANMYOME_HUMANBioGRID, MINT21900206 details
FHL1_HUMANTXNIP_HUMANBioGRID, MINT21900206 details
FHL1_HUMANDOCK9_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANENOA_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANCLMN_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANCSRP3_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANIBP5_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANLAMA4_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANMACF1_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANNFIL3_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANMYPC1_HUMANBioGRID, HPRD, IntAct16407297 23414517 details
FHL1_HUMANPAX7_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANPDLI3_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANTITIN_HUMANBioGRID, IntAct22778266 23414517 details
FHL1_HUMANZBT40_HUMANBioGRID, IntAct23414517 details
FHL1_HUMANSRPK1_HUMANBioGRID, IntAct23602568 details
FHL1_HUMANZNF16_HUMANUniProt21874239 details
FHL1_HUMANFHL2_HUMANBioGRID, HPRD12432079 details
FHL1_HUMANUBP15_HUMANBioGRID21219870 details
FHL1_HUMANAPRIO_HUMANBioGRID18482256 details
FHL1_HUMANRING1_HUMANBioGRID, HPRD14999091 15710417 details
FHL1_HUMANZEP3_HUMANBioGRID, HPRD14999091 details
FHL1_HUMANSMAD2_HUMANBioGRID19139564 details
FHL1_HUMANSMAD3_HUMANBioGRID19139564 details
FHL1_HUMANSMAD4_HUMANBioGRID19139564 details
FHL1_HUMANKC1D_HUMANBioGRID19139564 details
FHL1_HUMANSRF_HUMANBioGRID, HPRD15610731 details
FHL1_HUMANHIF1A_HUMANBioGRID23086815 details
FHL1_HUMANCHK2_HUMANBioGRID28094252 details
FHL1_HUMANMPIP3_HUMANBioGRID28094252 details
FHL1_HUMAN1433E_HUMANBioGRID28094252 details
FHL1_HUMANCBX4_HUMANHPRD15710417 details
FHL1_HUMANCRCM_HUMANIntAct17353931 details
FHL1_HUMANAAKB1_HUMANIntAct17353931 details
FHL1_HUMANHLAB_HUMANIntAct17353931 details
FHL1_HUMANIKKE_HUMANIntAct17353931 details
FHL1_HUMANEPB41_HUMANIntAct17353931 details
FHL1_HUMANESR1_HUMANBioGRID, IntAct19401155 22094188 details
FHL1_HUMANSUH_HUMANBioGRID, HPRD, MINT14999091 15710417 24952875 25609649 details
FHL1_HUMANA4_HUMANIntAct31413325 details
FHL1_HUMANBIN1_HUMANIntAct31413325 details
FHL1_HUMANKCNA5_HUMANBioGRID18281375 22053194 details
FHL1_HUMANEP300_HUMANBioGRID22219185 details
FHL1_HUMANCBP_HUMANBioGRID22219185 details
FHL1_HUMANAKT1_HUMANBioGRID22094188 details
FHL1_HUMANPKHG2_HUMANBioGRID27765816 28489964 details
FHL1_HUMANGBB1_HUMANBioGRID27765816 details
FHL1_HUMANSRC_HUMANBioGRID29434030 details
FHL1_HUMANFERM2_HUMANBioGRID29434030 details
FHL1_HUMANBCLF1_HUMANBioGRID29434030 details
FHL1_HUMANMPIP1_HUMANBioGRID28094252 details
FHL1_HUMANMPIP2_HUMANBioGRID28094252 details
FHL1_HUMAN1433S_HUMANBioGRID28094252 details